Literature DB >> 25606179

Photoageing skin of the elderly.

Sb Khoo1.   

Abstract

Year:  2010        PMID： 25606179      PMCID： PMC4170386     

Source DB:  PubMed          Journal:  Malays Fam Physician        ISSN： 1985-2274


× No keyword cloud information.
  9 in total

1.  Guidelines for the management of actinic keratoses.

Authors:  D de Berker; J M McGregor; B R Hughes
Journal:  Br J Dermatol       Date:  2007-02       Impact factor: 9.302

2.  Guidelines of care for actinic keratoses. Committee on Guidelines of Care.

Authors:  L A Drake; R I Ceilley; R L Cornelison; W L Dobes; W Dorner; R W Goltz; G F Graham; C W Lewis; S J Salasche; M L Turner
Journal:  J Am Acad Dermatol       Date:  1995-01       Impact factor: 11.527

Review 3.  Actinic keratoses.

Authors:  J P Callen; D R Bickers; R L Moy
Journal:  J Am Acad Dermatol       Date:  1997-04       Impact factor: 11.527

4.  Spontaneous remission of solar keratoses: the case for conservative management.

Authors:  R Marks; P Foley; G Goodman; B H Hage; T S Selwood
Journal:  Br J Dermatol       Date:  1986-12       Impact factor: 9.302

5.  Malignant transformation of solar keratoses to squamous cell carcinoma.

Authors:  R Marks; G Rennie; T S Selwood
Journal:  Lancet       Date:  1988-04-09       Impact factor: 79.321

6.  The risk of progression to invasive disease.

Authors:  R G Glogau
Journal:  J Am Acad Dermatol       Date:  2000-01       Impact factor: 11.527

7.  Metastases in dermatological patients with squamous cell carcinoma.

Authors:  R Møller; F Reymann; K Hou-Jensen
Journal:  Arch Dermatol       Date:  1979-06

8.  Health effects of sunlight exposure in the United States. Results from the first National Health and Nutrition Examination Survey, 1971-1974.

Authors:  A Engel; M L Johnson; S G Haynes
Journal:  Arch Dermatol       Date:  1988-01

9.  Non-melanoma skin cancer and solar keratoses. I. Methods and descriptive results of the South Wales Skin Cancer Study.

Authors:  I Harvey; S Frankel; R Marks; D Shalom; M Nolan-Farrell
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.